Population-Specific Polygenic Risk Scores Developed for the Han Chinese

Abstract
Predicting complex disease risks based on individual genomic profiles is an advancing field in human genetics.1,2 However, most genetic studies have focused on European populations, creating a global imbalance in precision medicine and underscoring the need for genomic research in non-European groups3,4. The Taiwan Precision Medicine Initiative (TPMI) recruited over half a million Taiwanese residents, providing the largest dataset of genetic profiles and electronic medical record data for the Han Chinese. Using extensive phenotypic data, we conducted the largest genomic analyses of Han Chinese across the medical phenome. These analyses identified population-specific genetic risk variants and novel findings on the genetic architecture of complex traits. We developed polygenic risk scores, demonstrating strong predictive performance for conditions such as cardiometabolic diseases, autoimmune disorders, cancers, and infectious diseases. We observed consistent findings in an independent sample from our Biobank and among East Asians in the UK Biobank and the All of Us Project. The identified genetic risks accounted for up to 9.1% of the disease burden variance in Taiwan. Our approach of characterizing the phenome-wide genomic landscape, developing population-specific risk prediction models, assessing their performance, and identifying the genetic impact on health, serves as a model for similar studies in other diverse study populations.
Competing Interest Statement
SDHH is a founder, shareholder, and serves on the Board of Directors of Genomic Prediction, Inc. (GP). EW is an employee and shareholder of GP.
Funding Statement
This study was funded in part by the Academia Sinica (40-05-GMM, AS-GC-110-MD02, and 236e-1100202 to P.-Y.K. and J.-Y.W.) and the National Development Fund, Executive Yuan (NSTC 111-3114-Y-001-001 to P.-Y.K.).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Institutional Review Boards of Taipei Veterans General Hospital (2020-08-014A), National Taiwan University Hospital (201912110RINC), Tri-Service General Hospital (2-108-05-038), Chang Gung Memorial Hospital (201901731A3), Taipei Medical University Healthcare System (N202001037), Chung Shan Medical University Hospital (CS19035), Taichung Veterans General Hospital (SF19153A), Changhua Christian Hospital (190713), Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUHIRB-SV(II)-20190059), Hualien Tzu Chi Hospital (IRB108-123-A),Far Eastern Memorial Hospital (110073-F), Ditmanson Medical Foundation Chia-Yi Christian Hospital (IRB2021128), Taipei City Hospital (TCHIRB-10912016), Koo Foundation Sun Yat-Sen Cancer Center (20190823A), Cathay General Hospital (CGH-P110041), Fu Jen Catholic University Hospital (FJUH109001) and Academia Sinica (AS-IRB01-18079), Taiwan. Written informed consent was obtained from the subjects in accordance with institutional requirements and the Declaration of Helsinki principles. All collected information was de-identified before statistical data analysis. The analysis with Health and Welfare Data Science Center (HWDC) was approved by Institutional Review Boards of Academia Sinica (AS-IRB-BM-23056). This research has been conducted using the UK Biobank Resource under UK Biobank Main Application 15326. Work with All of Us data was performed using the All of Us Researcher Workbench under the workspace, Duplicate of Prediction of Polygenic Traits.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The genotyping and electronic medical record (EMR) data analyzed in this study are from the Taiwan Precision Medicine Initiative (TPMI) with proper approval from the TPMI Data Access Committee. In compliance with the confidentiality laws governing genetic and health data in Taiwan, the de-identified TPMI data are kept in a secure server at the Academia Sinica and not released to the public.
Data availability
The genotyping and electronic medical record (EMR) data analyzed in this study are from the Taiwan Precision Medicine Initiative (TPMI) with proper approval from the TPMI Data Access Committee. In compliance with the confidentiality laws governing genetic and health data in Taiwan, the de-identified TPMI data are kept in a secure server at the Academia Sinica and not released to the public. All summary statistics, polygenic risk score (PRS) models, and GWAS results are freely available from the TPMI website (https://tpmi.ibms.sinica.edu.tw). Researchers requesting access to the individual genotyping and EMR data can do so on a collaborative basis. Instructions on requesting access to the data can be found on the TPMI’s official website (https://tpmi.ibms.sinica.edu.tw).
Subject Area
- Addiction Medicine (408)
- Allergy and Immunology (720)
- Anesthesia (214)
- Cardiovascular Medicine (3042)
- Dermatology (258)
- Emergency Medicine (456)
- Epidemiology (12963)
- Forensic Medicine (12)
- Gastroenterology (848)
- Genetic and Genomic Medicine (4773)
- Geriatric Medicine (441)
- Health Economics (747)
- Health Informatics (3029)
- Health Policy (1096)
- Hematology (405)
- HIV/AIDS (952)
- Medical Education (450)
- Medical Ethics (119)
- Nephrology (490)
- Neurology (4545)
- Nursing (242)
- Nutrition (671)
- Oncology (2365)
- Ophthalmology (666)
- Orthopedics (264)
- Otolaryngology (332)
- Pain Medicine (296)
- Palliative Medicine (86)
- Pathology (512)
- Pediatrics (1232)
- Primary Care Research (515)
- Public and Global Health (7136)
- Radiology and Imaging (1587)
- Respiratory Medicine (940)
- Rheumatology (456)
- Sports Medicine (396)
- Surgery (505)
- Toxicology (63)
- Transplantation (218)
- Urology (187)